The store will not work correctly when cookies are disabled.
N-2-ethylhexyl-D-galactonoamidine
ID: ALA3359676
PubChem CID: 118723762
Max Phase: Preclinical
Molecular Formula: C13H26N2O4
Molecular Weight: 274.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCC(CC)/N=C1\N[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C13H26N2O4/c1-3-5-6-8(4-2)14-13-12(19)11(18)10(17)9(7-16)15-13/h8-12,16-19H,3-7H2,1-2H3,(H,14,15)/t8?,9-,10+,11+,12-/m1/s1
Standard InChI Key: TZWAZIKJYVGDON-FXNBZEQJSA-N
Molfile:
RDKit 2D
19 19 0 0 0 0 0 0 0 0999 V2000
6.7852 -16.3851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7852 -17.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4904 -17.6068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1957 -17.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1957 -16.3851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4904 -15.9724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9046 -15.9786 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9028 -17.6119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4904 -18.4239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0780 -17.6119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0763 -15.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0739 -15.1614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9070 -15.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6159 -14.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6200 -13.9438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2005 -14.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2029 -13.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9144 -13.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9185 -12.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 2 0
4 8 1 6
3 9 1 1
2 10 1 1
1 11 1 1
11 12 1 0
7 13 1 0
13 14 1 0
15 14 1 0
13 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 274.36 | Molecular Weight (Monoisotopic): 274.1893 | AlogP: -0.60 | #Rotatable Bonds: 6 |
Polar Surface Area: 105.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.52 | CX Basic pKa: 7.65 | CX LogP: -0.42 | CX LogD: -0.86 |
Aromatic Rings: ┄ | Heavy Atoms: 19 | QED Weighted: 0.44 | Np Likeness Score: 1.15 |
References
1. Fan QH, Claunch KA, Striegler S.. (2014) Structure-activity relationship of highly potent galactonoamidine inhibitors toward β-galactosidase (Aspergillus oryzae)., 57 (21): [PMID:25295392] [10.1021/jm501111y] |